These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8730461)

  • 21. Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane.
    Locatelli F; Andrulli S; Del Vecchio L
    Contrib Nephrol; 1999; 125():173-81. PubMed ID: 9895439
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 27. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.
    Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin, oxidative metabolism and dialysis.
    Ionova D; Sepetlieva K; Tcachev K
    Nephron; 2000 Dec; 86(4):544. PubMed ID: 11124624
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis G and erythropoietin therapy in patients undergoing hemodialysis.
    Cengiz K; Günaydin M; Akpolat T; Pekbay A
    Nephron; 1998 Aug; 79(4):507. PubMed ID: 9689184
    [No Abstract]   [Full Text] [Related]  

  • 31. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythropoietin for the anemia of chronic renal failure.
    Schwartz AB; Prior J; Terzian L; Kahn B
    Am Fam Physician; 1988 Jun; 37(6):211-5. PubMed ID: 3289343
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 34. Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients.
    Buemi M; Allegra A; Aloisi C; Giacobbe MS; Frisina N
    Nephron; 1990; 56(2):218-9. PubMed ID: 2243581
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of treating uremia anemia with human recombinant erythropoietin].
    Litwin M; Grenda R; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients.
    Lago M; Pérez-García R; García de Vinuesa MS; Anaya F; Valderrábano F
    Nephron; 1996; 72(4):723-4. PubMed ID: 8730458
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin and its clinical promise.
    Erslev AJ; Schuster SJ; Caro J
    Eur J Haematol; 1989 Nov; 43(5):367-73. PubMed ID: 2693128
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of recombinant erythropoietin on sexual function in hemodialysis patients.
    Schaefer RM; Kokot F; Heidland A
    Contrib Nephrol; 1989; 76():273-81; discussion 281-2. PubMed ID: 2684527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.